Merck’s outspoken chairman and CEO, Ken Frazier, is

New Post Public Reply Private Reply Replies (4) Message Board
Chiro2019
597
Merck’s outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday.

Frazier, 66, will be succeeded as CEO on June 30 by Chief Financial Officer Robert Davis and will continue to serve on Merck’s board as executive chairman “for a transition period to be determined by the board,” the company said. Frazier, one of the few Black corporate leaders in the United States, has been Merck’s chief since January 2011.

https://www.cnbc.com/2021/02/04/merck-says-ke...ne-30.html

265877530_IMG_1270.jpg

312043981_IMG_1271.jpg

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials